-+ 0.00%
-+ 0.00%
-+ 0.00%

REGENERON PHARMACEUTICALS, - LOWER DOSES OF TREVOGRUMAB WELL TOLERATED WITH 77% EXPERIENCING AT LEAST ONE ADVERSE EVENT

Reuters·10/01/2026 15:32:14